Statement on House Oversight and Government Reform Committee Action on Pricing Strategies for MS Disease-Modifying Therapies

The House Oversight and Government Reform Committee has taken two actions this week on the pricing strategies for the MS disease-modifying therapies. First, on August 17, Representative Elijah E. Cummings (D-MD-7), Ranking Member of the House Committee on Oversight and Government Reform, and Representative Peter Welch (D-VT-AL), a senior Democrat on the Committee, sent letters to seven pharmaceutical companies that manufacture and distribute disease-modifying MS therapies in the U.S. requesting information on their pricing strategies for these treatments. The information is requested by August 31. Subsequently, a bipartisan group of…

Favicon of da :

Prosegui la lettura...
Traduci l'articolo...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati